European Companies Search Engine
UK funding (£741,793): Strategic development of stem cell-based therapies for vascular disease Ukri1 Oct 2010 UK Research and Innovation, United Kingdom
Overview
Text
Strategic development of stem cell-based therapies for vascular disease
| Abstract | Diseases of the heart and circulatory system are the main cause of death in the UK. While improvements in lifestyle are benefiting people at risk for these diseases, many already suffer from previous illness and others will nevertheless experience life-threatening episodes. Our work will strive to harness recent developments in the field of stem cell research to benefit those at risk for heart and circulatory diseases. This will be accomplished by studying the fundamental processes of cell growth, specialization and function that can be done in the Petri dish using modern microscopy and also by other imaging techniques. We will study cells that make up the normal and diseased heart and also those that form the lining and walls of the blood vessels. We expect our studies to provide the insights for future methods for diagnosis and treatment of lung disease and atherosclerosis, which together account for most cardiovascular disease risk. |
| Category | Research Grant |
| Reference | G1000847/1 |
| Status | Closed |
| Funded period start | 01/10/2010 |
| Funded period end | 31/03/2014 |
| Funded value | £741,793.00 |
| Source | https://gtr.ukri.org/projects?ref=G1000847%2F1 |
Participating Organisations
| University of Cambridge |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: University of Cambridge, Cambridge.
